While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

Hims & Hers has been expanding its presence in the weight management market, with its existing Novo partnership representing ...

The new weight-loss option will cut what ... year at current prices if every adult dealing with obesity took the drugs. Competition that drives down the cost of Wegovy and Zepbound could help ...

The announcement coincides with a federal deadline on May 22, for manufacturers to cease distributing less expensive, compounded versions of the drug. Novo Nordisk officials said the one-time ...

The announcement coincides with ... In February, Eli Lilly cut the monthly price for lower-dosage vials of its obesity drug Zepbound by $50 for consumers who pay cash via the drugmaker's ...

Days before the announcement, Novo Nordisk slashed its ... into the U.S. and signed an executive order that aims to cut drug prices by tying them to the lowest prices abroad.

Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA asset tirzepatide, respectively sold under the brand names Zepbound and ...

Its share price fell by a further 3 per cent on the Copenhagen stock exchange following the announcement ... its lead in the weight-loss market to Zepbound, an injection manufactured by rival ...

Surging competition from US drug compounders prompted Nono Nordisk to cut full year outlook ... on Wednesday morning following the earnings announcement and optimistic commentary from management.

As a result, Zepbound will be dropped from preferred coverage on CVS’s core formulary in favor of Novo's drug. The consensus indicates Lilly’s share price plunge was directly tied to CVS’s ...